Exencial Wealth Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$760K Buy
14,239
+3,354
+31% +$197K 0.02% 330
2025
Q4
$677K Sell
10,885
-6
-0.1% -$370 0.02% 346
2025
Q3
$654K Hold
10,891
0.02% 338
2025
Q2
$682K Sell
10,891
-138
-1% -$8.29K 0.02% 336
2025
Q1
$664K Sell
11,029
-66
-0.6% -$4.1K 0.02% 334
2024
Q4
$647K Buy
11,095
+16
+0.1% +$951 0.02% 339
2024
Q3
$656K Sell
11,079
-376
-3% -$21.5K 0.02% 324
2024
Q2
$642K Hold
11,455
0.02% 320
2024
Q1
$671K Sell
11,455
-185
-2% -$10.4K 0.03% 317
2023
Q4
$628K Sell
11,640
-509
-4% -$24.9K 0.03% 315
2023
Q3
$589K Sell
12,149
-2,098
-15% -$112K 0.03% 278
2023
Q2
$804K Sell
14,247
-91,519
-87% -$5.04M 0.04% 247
2023
Q1
$5.71M Sell
105,766
-9,125
-8% -$486K 0.3% 95
2022
Q4
$6.04M Sell
114,891
-3,799
-3% -$193K 0.32% 93
2022
Q3
$5.6M Buy
118,690
+2,114
+2% +$110K 0.34% 93
2022
Q2
$5.88M Sell
116,576
-3,755
-3% -$205K 0.33% 99
2022
Q1
$7.33M Sell
120,331
-824
-0.7% -$49.1K 0.37% 94
2021
Q4
$7.98M Buy
+121,155
New +$7.76M 0.39% 95
2021
Q3
Sell
-122,370
Closed -$7.36M 386
2021
Q2
$7.36M Buy
122,370
+1,608
+1% +$93K 0.4% 88
2021
Q1
$6.65M Buy
120,762
+8,394
+7% +$465K 0.39% 89
2020
Q4
$6.13M Buy
112,368
+17,202
+18% +$899K 0.42% 87
2020
Q3
$4.75M Buy
95,166
+3,900
+4% +$189K 0.25% 119
2020
Q2
$4.03M Buy
91,266
+3,270
+4% +$140K 0.35% 100
2020
Q1
$3.31M Buy
87,996
+876
+1% +$36.9K 0.59% 57
2019
Q4
$3.84M Buy
87,120
+204
+0.2% +$8.57K 0.66% 57
2019
Q3
$3.58M Sell
86,916
-1,956
-2% -$80.1K 0.77% 47
2019
Q2
$3.57M Sell
88,872
-3,690
-4% -$140K 0.83% 44
2019
Q1
$3.57M Sell
92,562
-2,226
-2% -$80.8K 0.85% 44
2018
Q4
$3.16M Sell
94,788
-6,672
-7% -$231K 0.85% 43
2018
Q3
$3.85M Sell
101,460
-8,370
-8% -$297K 0.89% 35
2018
Q2
$3.67M Sell
109,830
-8,490
-7% -$277K 1.02% 35
2018
Q1
$3.65M Sell
118,320
-11,760
-9% -$362K 1.09% 33
2017
Q4
$3.76M Sell
130,080
-1,650
-1% -$47.6K 1.13% 28
2017
Q3
$3.67M Buy
131,730
+396
+0.3% +$11K 1.21% 26
2017
Q2
$3.65M Sell
131,334
-2,490
-2% -$65.9K 1.49% 22
2017
Q1
$3.38M Buy
133,824
+7,170
+6% +$174K 1.47% 22
2016
Q4
$2.81M Buy
126,654
+444
+0.4% +$10.1K 1.19% 29
2016
Q3
$2.84M Buy
126,210
+3,240
+3% +$77.1K 1.26% 26
2016
Q2
$2.78M Buy
122,970
+420
+0.3% +$9.1K 1.25% 25
2016
Q1
$2.5M Sell
122,550
-4,890
-4% -$95K 1.18% 30
2015
Q4
$2.44M Buy
127,440
+2,064
+2% +$41.3K 1.21% 30
2015
Q3
$2.33M Sell
125,376
-858
-0.7% -$17.2K 1.14% 36
2015
Q2
$2.63M Sell
126,234
-1,404
-1% -$28.1K 1.67% 20
2015
Q1
$2.57M Buy
127,638
+4,470
+4% +$87.3K 1.08% 36
2014
Q4
$2.37M Buy
123,168
+13,266
+12% +$239K 1.05% 35
2014
Q3
$1.82M Buy
109,902
+4,302
+4% +$73.2K 0.8% 48
2014
Q2
$1.8M Sell
105,600
-4,158
-4% -$68K 0.77% 53
2014
Q1
$1.76M Buy
109,758
+1,428
+1% +$22.9K 0.73% 55
2013
Q4
$1.74M Sell
108,330
-870
-0.8% -$13K 0.79% 50
2013
Q3
$1.63M Buy
109,200
+3,030
+3% +$41.6K 0.76% 53
2013
Q2
$1.48M Buy
+106,170
New +$1.38M 0.74% 52

Other funds holding IHI

Exencial Wealth Advisors's IHI Position: Q1 2026 in Review

Exencial Wealth Advisors increased its iShares US Medical Devices ETF (IHI) stake by 31% in Q1 2026, buying an estimated $197K and bringing the position to 14,239 shares worth $760K. The position accounts for 0.02% of the portfolio, ranked #330.

Exencial Wealth Advisors first reported a position in IHI in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.98M in Q4 2021. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Exencial Wealth Advisors held 14,239 shares of iShares US Medical Devices ETF worth $760K as of Q1 2026.
  • Exencial Wealth Advisors bought 3,354 iShares US Medical Devices ETF shares in Q1 2026, an estimated $197K.
  • iShares US Medical Devices ETF made up 0.02% of Exencial Wealth Advisors's portfolio in Q1 2026, its #330 holding.
  • Exencial Wealth Advisors first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 51 quarters since.
  • Exencial Wealth Advisors's iShares US Medical Devices ETF position peaked at $7.98M in Q4 2021.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.